Literature DB >> 19161415

Regulation of interferon and Toll-like receptor signaling during macrophage activation by opposing feedforward and feedback inhibition mechanisms.

Xiaoyu Hu1, Soumya D Chakravarty, Lionel B Ivashkiv.   

Abstract

Activated macrophages and their inflammatory products play a key role in innate immunity and in pathogenesis of autoimmune/inflammatory diseases. Macrophage activation needs to be tightly regulated to rapidly mount responses to infectious challenges but to avoid toxicity associated with excessive activation. Rapid and potent macrophage activation is driven by cytokine-mediated feedforward loops, while excessive activation is prevented by feedback inhibition. Here we discuss feedforward mechanisms that augment macrophage responses to Toll-like receptor (TLR) ligands and cytokines that are mediated by signal transducer and activator of transcription 1 (STAT1) and induced by interferon-gamma (IFN-gamma). IFN-gamma also drives full macrophage activation by inactivating feedback inhibitory mechanisms, such as those mediated by interleukin-10 (IL-10), and STAT3. Priming of macrophages with IFN-gamma reprograms cellular responses to other cytokines, such as type I IFNs and IL-10, with a shift toward pro-inflammatory STAT1-dominated responses. Similar but partially distinct priming effects are induced by other cytokines that activate STAT1, including type I IFNs and IL-27. We propose a model whereby opposing feedforward and feedback inhibition loops crossregulate each other to fine tune macrophage activation. In addition, we discuss how dysregulation of the balance between feedforward and feedback inhibitory mechanisms can contribute to the pathogenesis of autoimmune and inflammatory diseases, such as rheumatoid arthritis and systemic lupus erythematosus.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19161415      PMCID: PMC2630590          DOI: 10.1111/j.1600-065X.2008.00707.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  113 in total

1.  Reprogramming of IL-10 activity and signaling by IFN-gamma.

Authors:  Carmen Herrero; Xiaoyu Hu; Wai Ping Li; Stuart Samuels; M Nusrat Sharif; Sergei Kotenko; Lionel B Ivashkiv
Journal:  J Immunol       Date:  2003-11-15       Impact factor: 5.422

2.  Cutting edge: different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-Fos.

Authors:  Sudhanshu Agrawal; Anshu Agrawal; Barbara Doughty; Andrew Gerwitz; John Blenis; Thomas Van Dyke; Bali Pulendran
Journal:  J Immunol       Date:  2003-11-15       Impact factor: 5.422

3.  The role of STAT1 in viral sensitization to LPS.

Authors:  Joan Durbin; Leslie Doughty; Ken Nguyen; Michael Caligiuri; Jeff Van Deusen; Christine Biron
Journal:  J Endotoxin Res       Date:  2003

Review 4.  Interferon-alpha: a new target for therapy in systemic lupus erythematosus?

Authors:  Mary K Crow
Journal:  Arthritis Rheum       Date:  2003-09

Review 5.  Type I interferon and autoimmune disease.

Authors:  Mary K Crow
Journal:  Autoimmunity       Date:  2003-12       Impact factor: 2.815

Review 6.  IL-6 signal transduction and its physiological roles: the signal orchestration model.

Authors:  D Kamimura; K Ishihara; T Hirano
Journal:  Rev Physiol Biochem Pharmacol       Date:  2003-04-05       Impact factor: 5.545

7.  Cutting edge: activation of Toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma.

Authors:  Vanessa Redecke; Hans Häcker; Sandip K Datta; Agnes Fermin; Paula M Pitha; David H Broide; Eyal Raz
Journal:  J Immunol       Date:  2004-03-01       Impact factor: 5.422

8.  IFN-alpha skews monocyte differentiation into Toll-like receptor 7-expressing dendritic cells with potent functional activities.

Authors:  Mohamad Mohty; Alexandra Vialle-Castellano; Jacques A Nunes; Daniel Isnardon; Daniel Olive; Béatrice Gaugler
Journal:  J Immunol       Date:  2003-10-01       Impact factor: 5.422

Review 9.  Interferon-gamma: an overview of signals, mechanisms and functions.

Authors:  Kate Schroder; Paul J Hertzog; Timothy Ravasi; David A Hume
Journal:  J Leukoc Biol       Date:  2003-10-02       Impact factor: 4.962

Review 10.  Type I interferon modulation of cellular responses to cytokines and infectious pathogens: potential role in SLE pathogenesis.

Authors:  Lionel B Ivashkiv
Journal:  Autoimmunity       Date:  2003-12       Impact factor: 2.815

View more
  121 in total

Review 1.  Interferons in autoimmune and inflammatory diseases: regulation and roles.

Authors:  Divaker Choubey; Kamal D Moudgil
Journal:  J Interferon Cytokine Res       Date:  2011-12       Impact factor: 2.607

2.  Integrins limit the Toll.

Authors:  Terry K Means; Andrew D Luster
Journal:  Nat Immunol       Date:  2010-08       Impact factor: 25.606

Review 3.  Toll-like receptor signaling: a potential link among rheumatoid arthritis, systemic lupus, and atherosclerosis.

Authors:  QiQuan Huang; Richard M Pope
Journal:  J Leukoc Biol       Date:  2010-05-19       Impact factor: 4.962

4.  α-Galactosylceramide protects mice from lethal Coxsackievirus B3 infection and subsequent myocarditis.

Authors:  C Y Wu; Y Feng; G C Qian; J H Wu; J Luo; Y Wang; G J Chen; X K Guo; Z J Wang
Journal:  Clin Exp Immunol       Date:  2010-08-19       Impact factor: 4.330

5.  Glycoprotein 96 perpetuates the persistent inflammation of rheumatoid arthritis.

Authors:  Qi-Quan Huang; Renee E Koessler; Robert Birkett; Andrea Dorfleutner; Harris Perlman; G Kenneth Haines; Christian Stehlik; Christopher V Nicchitta; Richard M Pope
Journal:  Arthritis Rheum       Date:  2012-11

6.  IFN-γ Prevents Adenosine Receptor (A2bR) Upregulation To Sustain the Macrophage Activation Response.

Authors:  Heather B Cohen; Amanda Ward; Kajal Hamidzadeh; Katya Ravid; David M Mosser
Journal:  J Immunol       Date:  2015-09-09       Impact factor: 5.422

7.  Notch signaling regulates the phosphorylation of Akt and survival of lipopolysaccharide-activated macrophages via regulator of G protein signaling 19 (RGS19).

Authors:  Naunpun Sangphech; Barbara A Osborne; Tanapat Palaga
Journal:  Immunobiology       Date:  2014-04-06       Impact factor: 3.144

8.  Brief Report: Interferon-γ-Mediated Immunopathology Potentiated by Toll-Like Receptor 9 Activation in a Murine Model of Macrophage Activation Syndrome.

Authors:  Lehn K Weaver; Niansheng Chu; Edward M Behrens
Journal:  Arthritis Rheumatol       Date:  2018-11-24       Impact factor: 10.995

Review 9.  The role of glycoprotein 96 in the persistent inflammation of rheumatoid arthritis.

Authors:  Qi-Quan Huang; Richard M Pope
Journal:  Arch Biochem Biophys       Date:  2012-12-17       Impact factor: 4.013

Review 10.  Cross-regulation of signaling by ITAM-associated receptors.

Authors:  Lionel B Ivashkiv
Journal:  Nat Immunol       Date:  2009-03-19       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.